文献速递心境障碍

一种简单的血小板生物标志物与重度抑郁障碍症状严重程度相关

A simple platelet biomarker is associated with symptom severity in major depressive disorder.
PubMed 文献 · Mol Psychiatry · 2025-03-04

研究在积极治疗中的抑郁受试者和健康对照中,用前列腺素E1刺激评估血小板腺苷酸环化酶与Gsα的偶联,并以QIDS-C16在相隔2周的两次访视中测量症状严重程度阈值。QIDS-C16评分与PGE1刺激反应在两次访视中均呈负相关(rs=-0.33、rs=-0.60),轻度-中度抑郁症状者(QIDS-C16≥6)的PGE1刺激反应显著低于无症状者(QIDS-C16<6)或健康对照。作者认为该简易血小板检测可能有助于评估抑郁受试者的临床状态,但需更大规模研究。

要点

  • QIDS-C16评分与PGE1刺激反应在两次访视中均呈负相关(rs=-0.33、rs=-0.60)。
  • QIDS-C16≥6的轻中度抑郁受试者PGE1刺激反应显著低于QIDS-C16<6者(p=0.001)和健康对照(p=0.002)。
  • QIDS-C16≥10的中度抑郁受试者PGE1反应在所有受试者中最低(Fisher精确检验=0.012)。

核心结论

  • 结果支持作者早先的发现,即一种简易、具备高通量能力的血小板检测可能是有用的生物标志物,用于评估抑郁受试者的临床状态。
  • 需要更大规模的研究来评估该生物标志物用于诊断和治疗反应的价值。

研究设计与样本

  • 研究在积极治疗中的抑郁受试者和健康对照中,用前列腺素E1刺激评估血小板腺苷酸环化酶与Gsα的偶联。
  • 用QIDS-C16在相隔2周的两次研究访视中测量症状严重程度阈值。

主要发现

  • QIDS-C16评分和PGE1刺激反应在两次研究访视之间保持稳定。
  • QIDS-C16与PGE1刺激反应在每次访视时均呈负相关(rs=-0.33、rs=-0.60)。
  • QIDS-C16≥6的轻中度抑郁症状MDD受试者PGE1刺激反应显著低于QIDS-C16<6的无症状MDD受试者(p=0.001)和健康对照(p=0.002)。
  • QIDS-C16≥10的中度抑郁症状MDD受试者PGE1反应在所有受试者中最低(Fisher精确检验=0.012)。

关键数值与推荐

  • 轻中度抑郁症状定义为QIDS-C16≥6,无症状定义为QIDS-C16<6。
  • 中度抑郁症状定义为QIDS-C16≥10。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要更大规模的研究来评估该生物标志物用于诊断和治疗反应的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Previous studies have shown that the heterotrimeric G protein, Gsalpha (Gsα), is ensconced predominantly in lipid rafts in acutely depressed subjects with major depressive disorder (MDD) in contrast to healthy controls, and that effective antidepressant treatment (ADT) facilitates translocation of Gsα from lipid rafts. The measurement of Gsα via prostaglandin E1 stimulation of adenylyl cyclase (PGE1 stimulation) has been proposed as a peripheral biomarker for assessing clinical status in MDD. We examined the Gsα biomarker in a new study. PGE1 stimulation was used to assess the coupling of Gsα with platelet adenylyl cyclase in depressed subjects in active treatment and healthy controls. The Quick Inventory of Depressive Symptomatology (QIDS-C16) measured thresholds of symptom severity at two study visits spaced 2 weeks apart. QIDS-C16 scores and PGE1 stimulated responses were stable between the two study visits. The QIDS-C16 was inversely correlated with PGE1 stimulated responses at each visit (rs = -0.33, rs = -0.60, respectively). MDD subjects with mild-moderate depressive symptoms (defined by QIDS-C16 ≥ 6) had significantly lower PGE1 stimulated responses than asymptomatic MDD subjects (QIDS-C16 < 6) or healthy controls (p = 0.001 and 0.002 respectively). MDD subjects with moderate depressive symptoms (QIDS-C16 ≥ 10) had the lowest PGE1 responses of all subjects (Fisher's exact = 0.012). These results support our earlier findings that a simple, high-throughput-capable platelet assay may be a useful biomarker to assess the clinical status of depressed subjects. Larger studies are needed to evaluate the utility of this biomarker for diagnosis and treatment response.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Gunay A, Targum SD, Leow AD, et al. A simple platelet biomarker is associated with symptom severity in major depressive disorder. Mol Psychiatry. 2025. PMID: 40038544. doi:10.1038/s41380-025-02941-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。